Automation Scientist, Technology Development

The Role:

The Technology Development group at Life Edit discovers new genome editing systems and establishes new editing capabilities and optimizes them to support efforts developing curative gene editing therapies and gene edited cell therapies. We are seeking enthusiastic, competent, and self-motivated individuals to work in our company.  We are looking for a Scientist to develop and support automated mammalian cell screening assays.

Here’s What You’ll Do:

• Work with scientists to develop automated protocols for cell screening assays.
• Support both standalone liquid handlers and fully integrated automated workcells.
• For the first 6 months to 1 year this position will be expected to perform cell screening assays using automation.
• Train other users on best practices for using various automated platforms.
• Provide troubleshooting support for the automated platforms.
• Be part of a growing automation team and make recommendations for our automation roadmap.
• Push the boundaries for what automation can do for gene editing workflows.

Requirements:

• Bachelor’s degree in Biology, Biochemistry, Cell Biology, or a related field with 5+ years of experience.
• 3+ years of experience with developing, writing, and maintaining protocols on automated liquid handlers (Tecan, Hamilton, Agilent, Beckman, etc.).
• Experience with integrated automated workcells and scheduling software preferred (VWorks, Cellario, Green Button Go, etc.).
• Programming knowledge in Python, C#, JavaScript, etc.
• Experience with culturing and transfecting cells and performing subsequent cell screening assays.
• Experience with modern molecular biology techniques including DNA/RNA extraction, PCR, qPCR, NGS and flow cytometry.
• Experience maintaining and organizing ELN documentation
• Demonstrated ability to work independently and collaborate in a team-oriented environment
• Outstanding written and verbal communication skills

Why join Life Edit Therapeutics?

Life Edit Therapeutics, an ElevateBio portfolio company, is a gene editing company on a mission to rewrite the future by curing disease, making any edit, anywhere. Life Edit has built a world-class genome editing platform with one of the world’s largest and most diverse collections of novel RNA-guided nucleases (RGNs) and base editors. The company’s next-generation editing systems will propel the development of novel human therapeutics by enabling ex vivo engineering for cell therapies and regenerative medicines and in vivo delivery of gene therapies.

Our Vision:  To pave the way to faster, safer, gene editing therapeutics that cure disease and improve patient lives

Life Edit is committed to equal employment opportunity and non-discrimination for all employees and qualified applicants without regard to a person’s race, color, gender, age, religion, national origin, ancestry, disability, veteran status, genetic information, sexual orientation or any characteristic protected under applicable law. Life Edit will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.